Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

282 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2947 (91%)

3240

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT AMLODIPINE 5MG TABLET Resolved 2022-12-15 2023-02-16 178518
ACT AMLODIPINE 10MG TABLET Resolved 2021-09-30 2021-10-07 146443
ACT AMLODIPINE 2.5MG TABLET Resolved 2017-03-17 2017-09-19 3348
ACT AMLODIPINE 5MG TABLET Resolved 2023-02-09 2023-04-28 184204
ACT AMLODIPINE 5MG TABLET Resolved 2020-11-06 2021-01-07 127998
ACT AMLODIPINE 10MG TABLET Resolved 2020-11-06 2021-01-21 128034
ACT AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068
ACT AMPHETAMINE XR 1.25MG 1.25MG 1.25MG 1.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61336
ACT AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
ACT AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-05-06 131679
ACT AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-15 2021-09-09 142610
ACT AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2021-09-23 2021-10-14 146092
ACT AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Avoided shortage 2021-05-20 2021-07-08 139722
ACT AMPHETAMINE XR 5MG 5MG 5MG 5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60075
ACT AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2021-03-25 2021-05-20 136286
ACT AMPHETAMINE XR 6.25MG 6.25MG 6.25MG 6.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61330
ACT AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-03-11 131676
ACT AMPHETAMINE XR 7.5MG 7.5MG 7.5MG 7.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61333
ACT ANASTROZOLE 1MG TABLET Resolved 2020-01-24 2021-01-28 104374
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-09-25 2020-10-22 125031

Showing 1 to 20 of 3240

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CEFTRIAXONE SODIUM FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2025-05-28 2025-05-28 258691
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2025-05-27 2025-05-27 258359
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2021-02-12 2021-02-12 133886
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 2G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14021
CLOXACILLIN SODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14014
COUGH SYRUP WITH CODEINE 30MG 3.3MG 100MG SYRUP SYRUP Reversed 2025-05-28 2025-06-03 258600
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344